Live Breaking News & Updates on Liberalized Pricing
Stay updated with breaking news from Liberalized pricing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pune divisional commissioner Saurabh Rao and district collector Rajesh Deshmukh visited the plant on Wednesday. Share Via Email | A+A A- By PTI PUNE: Biovet Pvt Ltd, an associate firm of Bharat Biotech, is confident of making a plant at Manjari in Pune fully functional for vaccine production by August- end, a senior administrative official has said. Hyderabad-based Bharat Biotech is the manufacturer of Covaxin, one of the two vaccines being used in the nationwide COVID-19 inoculation drive. Pune divisional commissioner Saurabh Rao and district collector Rajesh Deshmukh visited the plant on Wednesday. The Bombay High Court recently permitted Biovet to take possession of a ready-to-use vaccine manufacturing plant, built on a 12-hectare plot at Manjari in Pune, to produce Covaxin. ....
URL copied Image Source : PTI (FILE) COVID Vaccine: Centre to supply 192 lakh doses to states in 15 days free of cost The Centre will provide as many as 192 lakh doses of Covid-19 vaccines to the states and Union Territories free of cost this month. According to a statement issued by the Health Ministry, doses will be shared with the states and UTs between May 16 and 31. Between May 16 and 31, 191.99 lakh doses of Covishield and Covaxin will be supplied to the States and UTs, free of cost. This will include 162.5 lakh of Covishield and 29.49 lakh of Covaxin, the ministry said. The delivery schedule will be shared in advance, it said, adding that states have been requested to direct the concerned officials to ensure rational and judicious utilization of allocated doses and minimize the vaccine wastage. ....
Updated: Between May 1-15, more than 1.7 crore doses made available to States free of cost Share Article AAA A medical staff member shows vials of COVID-19 vaccine in New Delhi. | Photo Credit: SUSHIL KUMAR VERMA Between May 1-15, more than 1.7 crore doses made available to States free of cost The Central government would supply 191.99 lakh doses of vaccines (162.5 lakh Covishield and 29.49 lakh Covaxin) free of cost to the States and Union Territories (UT) during May 16-31, said a release issued by the Union Health Ministry on Friday. “The delivery schedule for this allocation will be shared in advance. States have been requested to direct the concerned officials to ensure rational and judicious utilization of allocated doses and minimize the vaccine wastage,” it stated. ....
"There have been reports in a section of the media followed by some uninformed tweets alleging delay in licensing for Covaxin and delayed approval for technology transfer for manufacturing Covaxin vaccine in the country," the ministry said in its statement. ....
NEW DELHI: The government on Thursday dismissed as completely baseless and factually incorrect reports in a section of media followed by some tweets alleging delay in licensing for Covaxin and delayed approval for technology transfer for manufacturing the vaccine in the country. The Union government is consistently and pro-actively working to secure and enhance the availability of vaccines, the Health Ministry said, adding that Government of India is pro-actively engaging with foreign vaccine manufacturers like Moderna, Pfizer to apply for emergency use authorisation in India so that these vaccines can be easily imported and made available in the country. Simultaneously, Government of India, along with other like-minded countries, is also stressing on IPR waiver for COVID-19 vaccines. These two interventions, taken in conjunction, will ensure easy availability of vaccines not only in India but globally too, the ministry said in its statement. ....